Subscribe to RSS
DOI: 10.1055/s-0038-1651189
Coagulation Factors and Components of the Fibrinolytic System in Lymph and Blood in Dogs
This investigation was supported by grants from the Swedish Medical Research Council (B67-17X-759-02, B67-19X-87-03).Publication History
Publication Date:
27 June 2018 (online)
Summary
Thoracic duct lymph of the dog was compared with blood regarding the concentration of various coagulation factors, coagulation properties, and components of the fibrinolytic system.
The recalcification time for lymph was almost twice as long as for blood. The quotients between the concentration of the coagulation factors in the lymph and blood varied considerably. For fibrinogen the lymph/blood concentration ratio was 1/3, for factor V 1/4, for factor VIII 1/4, for factor IX 2/3 and for P & P 1/2.
The fibrinolytic activity in the lymph was lower than in the blood and no split products were found in the lymph. The lymph/blood concentration ratio was 1/2 for plasminogen and 2/3 for the urokinase inhibitor activity.
-
References
- 1 Andersson L, Nilsson I.M, Olow B. Fibrinolytic activity in man during surgery. Thrombos. Diathes. haemorrh. (Stuttg.) 1962; 7: 391
- 2 Astrup T, Müllertz S. The fibrin plate method for estimating fibrinolytic activity. Arch. Biochem 1952; 40: 346
- 3 Bergström K, Werner B. Proteins in human thoracic duct lymph. Acta chir. scand. 1966; 131: 413
- 4 Blombäck B, Blombäck M. Purification of human and bovine fibrinogen. Arkiv Kemi 1956; 10: 415
- 5 Blomstrand R, Nilsson I.M, Dahlbäck O. Coagulation studies on human thoracic duct lymph. Scand. J. clin. Lab. Invest. 1963; 15: 248
- 6 Brinkhous K.M, Walker S.A. Prothrombin and fibrinogen in lymph. Amer. J. Physiol. 1941; 132: 666
- 7 Fantl P, Nelson J.F. Coagulation in lymph. J. Physiol. 1953; 122: 33
- 8 Gram H.C. Studier over fibrinmengden i menniskets blod og plasma. Steen Hasselbacks førlag, Kobenhavn 1921
- 9 Greig H.B.W. Inhibition of fibrinolysis by alimentary lipaemia. Lancet 1956; II: 16
- 10 Grotte G. Passage of dextran molecules across the blood-lymph barrier. Acta chir. scand., Suppl. 211 1956
- 11 Hansen H.G, Aepinus K. Gerinnungsfaktoren in der Lymphe. Thrombos. Diathes. haemorrh. (Stuttg.) 1960; 4: 435
- 12 Hansen H.G, Kämpfer M. Gerinnungsfaktoren in der Lymphe. Thrombos. Diathes. haemorrh. (Stuttg.) 1962; 7: 106
- 13 Hedner U, Nilsson I.M. Determination of plasminogen in human plasma by a casein method. Thrombos. Diathes. haemorrh. (Stuttg.) 1965; 14: 545
- 14 Howell W.H. The coagulation of lymph. Amer. J. Physiol. 1914; 35: 483
- 15 Jacobsson, B.: To be published.
- 16 von Kaulla K.N, Pratt E.B. Influence of intravenously administered heparin on clotting of lymph in the dog. Amer. J. Physiol. 1956; 187: 89
- 17 Langdell R.D, Bowersox L.W, Weaver R.A, Gibson W.S. Coagulation properties of canine thoracic-duct lymph. Amer. J. Physiol. 1960; 199: 626
- 18 Niléhn J.-E, Robertson B. On the degradation products of fibrinogen or fibrin after infusion of streptokinase in patients with venous thrombosis. Scand. J. Haemat. 1965; 2: 267
- 19 Nilsson I.M, Blombäck M, von Francken I. On an inherited autosomal haemorrhagic diathesis with antihaemophilic globulin (AHG) deficiency and prolonged bleeding time. Acta med. scand. 1957; 159: 35
- 20 Nilsson I.M, Blombäck M, Ramgren O. Haemophilia in Sweden. Acta med. scand. 1961; 170: 665
- 21 Nilsson I.M, Olow B. Fibrinolysis induced by streptokinase in man. Acta chir. scand. 1962; 123: 247
- 22 Olow B, Nilsson I.M. Determination of fibrinogen and fibrinogenolytic activity. Thrombos. Diathes. haemorrh. (Stuttg.) 1962; 8: 297
- 23 Owren P.A, Aas K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand. J. clin. Lab. Invest. 1951; 3: 201
- 24 Paraskevas M, Nilsson I.M, Martinsson G. A method for determining serum inhibitors of plasminogen activation. Scand. J. clin. Lab. Invest. 1962; 14: 138
- 25 Stutman L.J, Dumont A.E, Shinowara G.Y. Coagulation factors in human lymph and plasma. Amer. J. med. Sci. 1965; 250: 292
- 26 Wolf P. A modification for routine laboratory use of Stefaninis method of estimating factor V in human oxalated plasma. J. clin. Path. 1953; 6: 34